VMD (Viemed Healthcare) Research & Development: $2.8 Mil (TTM As of Mar. 2026)


VMD Viemed Healthcare Inc VMD
93 GF Score
Price $12.16
GF Value $10.90
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Viemed Healthcare Research & Development?

Viemed Healthcare VMD +0.70% 93 Research & Development is $2.8 Mil as of Mar. 2026. GuruFocus rates VMD with a GF Score™ of 93/100 and a GF Value™ of $10.90 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Viemed Healthcare's Research & Development for the three months ended in Mar. 2026 was $0.6 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $2.8 Mil.

Viemed Healthcare  (NAS:VMD) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Viemed Healthcare Research & Development Related Terms

Viemed Healthcare Research & Development Historical Data

* Premium members only.

The historical data trend for Viemed Healthcare's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viemed Healthcare Research & Development Chart

Viemed Healthcare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.11 2.70 2.78 3.07 3.02

Viemed Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.80 0.85 0.78 0.60 0.58
VMD
93GF Score
Viemed Healthcare Inc VMD
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viemed Healthcare Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $2.8 Mil mean?
Viemed Healthcare (VMD) has a Research & Development of $2.8 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Viemed Healthcare and its competitors.
Is Viemed Healthcare's Research & Development too high?
Viemed Healthcare's current Research & Development is $2.8 Mil. Overall, Viemed Healthcare has a GF Score™ of 93/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Viemed Healthcare's Research & Development compare to DCTH and VREX?
Viemed Healthcare's Research & Development of $2.8 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Viemed Healthcare and its competitors. Viemed Healthcare's current Research & Development is $2.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viemed Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Viemed Healthcare (VMD) is currently considered Modestly Overvalued. The stock's GF Value™ is $10.90, compared to a current price of $12.16 — trading 11.6% above its estimated fair value. The current Research & Development is $2.8 Mil. Viemed Healthcare's overall GF Score™ is 93/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Viemed Healthcare (VMD), the current Research & Development is $2.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Viemed Healthcare (VMD) Overvalued in 2026?

Based on GuruFocus' analysis, Viemed Healthcare stock appears to be overvalued. The current stock price of $12.16 is trading 11.6% above its estimated GF Value™ of $10.90. GuruFocus considers Viemed Healthcare to be Modestly Overvalued.

Key valuation signals for VMD:

  • Research & Development: $2.8 Mil
  • GF Value™: $10.90 vs. price of $12.16 (11.6% above fair value)
  • GF Score™: 93/100 with 7 warning signs

No single metric tells the full story. See the VMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Viemed Healthcare Business Description

Other Exchanges VIJ:Germany
Address 625 E. Kaliste Saloom Road, Lafayette, LA, USA, 70508
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.
93GF Score

Get the complete analysis for VMD

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.16
Price
$10.90
GF Value